Rokos Capital Management (UK)’s Eli Lilly LLY Stock Holding History

Rokos Capital Management (UK)’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,950	Closed	-$9.62M	–	216
2025 Q4	$9.62M	Buy	+8,950	New	+$8.56M	0.04%	127
2025 Q3	–	Sell	-13,093	Closed	-$10.2M	–	199
2025 Q2	$10.2M	Buy	+13,093	New	+$10.2M	0.04%	156
2025 Q1	–	Sell	-24,816	Closed	-$19.2M	–	171
2024 Q4	$19.2M	Sell	24,816 -42,743	-63%	-$35.4M	0.19%	66
2024 Q3	$59.8M	Buy	+67,559	New	+$60.7M	0.97%	30
2024 Q2	–	Sell	-80,576	Closed	-$62.7M	–	114
2024 Q1	$62.7M	Buy	+80,576	New	+$57.3M	0.33%	32
2021 Q2	–	Sell	-202,164	Closed	-$37.5M	–	151
2021 Q1	$37.5M	Buy	+202,164	New	+$39.5M	0.56%	34

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Rokos Capital Management (UK)'s LLY Position: Q1 2026 in Review

Rokos Capital Management (UK) sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 8,950 shares — an estimated $9.62M sold.

Rokos Capital Management (UK) first reported a position in LLY in Q1 2021 and held it in 6 quarters. The position peaked at $62.7M in Q1 2024. 4,374 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Rokos Capital Management (UK) reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
Rokos Capital Management (UK) sold 8,950 Eli Lilly shares in Q1 2026, an estimated $9.62M.
Rokos Capital Management (UK) first reported a position in Eli Lilly in Q1 2021 and held it in 6 quarters.
Rokos Capital Management (UK)'s Eli Lilly position peaked at $62.7M in Q1 2024.
4,374 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Rokos Capital Management (UK)'s 13F filing for Q1 2026, filed 15 May 2026.